Rice Derivative Market Size & Share 2026-2035

Rice Derivative Market Size

The global rice derivative market was valued at USD 20.2 billion in 2025 and is projected to reach USD 35.5 billion by 2035, expanding at a CAGR of 5.9% from 2026 to 2035. According to the latest report published by Global Market Insights Inc., demand reaches USD 21.3 billion in 2026 after a 5.5% CAGR during 2022–2025. Growth is moving beyond commodity rice processing as food formulators, nutrition brands, and personal care producers purchase specialized starches, proteins, oils, and bran-derived bioactives. The decisive change is mix: high-volume starch and flour remain the revenue base, while rice protein and stabilized bran extracts raise value per unit in premium applications.

The market measures demand-side revenue for rice starch, bran, flour, oil, protein, germ, fats, and other rice-derived ingredients purchased across processed food, bakery, beverages, nutritional products, infant food, pharmaceutical, cosmetic, and related applications. It excludes unprocessed paddy and finished consumer products whose rice-derived ingredient cost cannot be isolated. The USD 15.3 billion expansion from the 2025 base to 2035 reflects both volume growth and a richer product mix, particularly in rice protein isolates, functional oils, and clean-label starches.

Sizing uses demand-side triangulation across ingredient use in downstream applications, segment allocation, regional demand patterns, and company participation. Rice starch supplied the largest ingredient pool at 29.2% share in 2025, while rice protein will post the fastest ingredient growth at 8.0% CAGR. Asia Pacific leads with USD 7.51 billion in 2025, whereas Europe will grow fastest at 6.8% CAGR through 2035.

Key Drivers

Gluten-free reformulation creates recurring demand because rice flour and starch can replace wheat-derived inputs without imposing strong flavor or color changes. Food labeling rules strengthen the commercial case for dedicated gluten-free ingredient chains. EU Regulation 1169/2011 requires prominent allergen declarations, and FDA gluten-free labeling requirements establish a clear compliance framework in the United States. ^{[1]European Commission, “Food Information to Consumers Regulation and Farm-to-Fork Strategy”, ec.europa.eu [2]U.S. Food and Drug Administration, “Gluten-Free Food Labeling”, fda.gov} The result is durable purchasing demand from bakery, infant nutrition, and processed food producers rather than a short-lived consumer trend.

Plant-based expansion favors rice protein where allergen management, non-GMO positioning, and taste neutrality matter more than maximum protein concentration. The category competes directly with soy and pea, but enzymatic hydrolysis and protein fractionation improve digestibility and broaden use in sports nutrition, meal replacements, and beverage powders. Axiom Foods introduced Oryzatein® 2.0 in January 2025 as a commercial example of this move toward higher-performance rice protein. ^{[3]Axiom Foods press release, “Oryzatein 2.0”, axiomfoods.com}

Functional food demand broadens the addressable market for stabilized bran, gamma-oryzanol-rich oil, and hydrolyzed protein. World Health Organization material on functional-food trends places the global nutraceutical market on a trajectory toward USD 722 billion by 2030. ^{[4]World Health Organization, “Functional Food Trends”, who.int} Higher-value nutritional applications also reduce reliance on commodity starch cycles.

Key Restraints

Paddy-price volatility directly affects input costs for every derivative category. In September 2024, the Government of India allowed the Food Corporation of India to sell up to 23 lakh metric tons of rice to distilleries for ethanol blending, redirecting feedstock from food-grade channels. ^{[5]Food Corporation of India, “Rice Supply for Ethanol Blending”, fci.gov.in} Manufacturers with narrow procurement networks face margin pressure when public policy, monsoon outcomes, or export controls tighten supply. Vertical integration and multi-origin sourcing therefore matter most in rice bran oil and bulk flour.

Soy, pea, and oat ingredients retain larger manufacturing bases in many applications. Rice derivatives must win on a narrower set of attributes: allergen freedom, sensory neutrality, fine particle size, clean-label compatibility, or bioactive content. Commodity positioning alone exposes suppliers to price competition. Product differentiation through standardized functionality is the more defensible route.

Rice Derivative Market Segment Analysis

By Ingredient Type

Rice starch remains the largest ingredient category at 29.2% share, supported by its use as a thickener, binder, filler, and texture modifier. Ingredion’s NOVATION® Lumina and PURITY™ Alpha grades, BENEO’s Remygel® and Remypure®, and Ebro Ingredients’ OryzaMYL® portfolio show how native, waxy, high-amylose, and organic variants extend the category into clean-label food, pharmaceutical, and cosmetic applications. Rice flour is the second core formulation platform, with PGP International’s PAC® pre-gelatinized flour and Ebro’s OryzaFINE® targeting cold-water swelling, fine texture, and specialty applications. Rice starch will grow more slowly than the total market because it begins from a mature base, yet its scale anchors supplier utilization.

Rice bran, rice oil, germ, fats, and other co-products increasingly depend on stabilization and fractionation. Rice bran’s 6.2% CAGR reflects use in fiber enrichment, oil extraction, and nutraceutical applications. A.P. Refinery’s extraction operations and Tsuno Food Industrial’s gamma-oryzanol, ferulic acid, and glucosylceramide lines demonstrate the value of moving beyond crude bran. Rice oil will grow at 6.0% CAGR as food manufacturers and consumers favor its high-temperature performance and health-oriented positioning. The more consequential shift is value recovery from milling streams that once had limited commercial use.

Rice protein will lead ingredient growth at 8.0% CAGR, rising from USD 1.98 billion in 2025 to USD 4.27 billion by 2035. Axiom Foods’ Oryzatein® 2.0, BENEO’s Remypro® N80+, Panjin Hetian Food’s protein powders and peptides, and Roquette’s NUTRALYS® Rice Protein demonstrate the widening commercial base. Protein’s hypoallergenic profile supports sports nutrition, clinical nutrition, and beverage formulation. By 2030, blends and hydrolyzed formats will matter more than conventional concentrates because customers are purchasing digestibility, solubility, and sensory performance.

By Nature

Conventional products held 68.3% share in 2025 because mass-market food processing requires large volumes at accessible price points. Conventional starch, flour, and refined oil will remain dominant through 2035, supported by expanding processed food demand in Asia Pacific, the Middle East, and Latin America. Their 5.7% CAGR still represents substantial absolute revenue growth.

Organic derivatives will outpace the total market at 6.0% CAGR. The European Union’s Farm-to-Fork Strategy targets 25% of agricultural land under organic farming by 2030, expanding both the policy support and feedstock rationale for certified ingredients. BENEO, Ingredion, and Ebro Ingredients each offer organic rice ingredient formats. Organic rice bran oil carries the strongest premium, but certification availability limits rapid volume scaling.

By Form

Powder accounted for 57.4% of market revenue in 2025. Rice starch, flour, protein, dried bran, and germ powders fit existing bulk logistics and industrial blending systems, which preserves their leadership despite a 5.4% CAGR. PAC® flour, Remyflo®, and rice protein powders from Panjin Hetian Food exemplify formats built for controlled dispersion and long shelf life.

Liquid products will expand fastest at 7.0% CAGR, driven mainly by rice bran oil, rice syrup, liquid starch dispersions, and liquid protein formats. Fortune® Rice Bran Oil from Adani Wilmar, Freedom® Rice Bran Oil from Gemini Edibles & Fats, Wilmar’s refined oil range, and Tsuno’s expeller-pressed formats address both retail and industrial demand. Granular and pellet formats retain a targeted role where dust control, flow properties, or controlled dissolution matter. Form choice increasingly reflects process economics, not only ingredient chemistry.

By Application

Processed food led application demand at 25.4% share in 2025 because starch, flour, and oil support sauces, snacks, ready meals, coatings, and convenience products. Bakery remains a major gluten-free channel, while beverages use rice protein, rice syrup, and dispersions in dairy alternatives and functional drinks. PGP International, Riceland Foods, and Shafi Gluco Chem supply formats relevant to these high-volume applications.

Nutritional products and cosmetics will each grow at 6.2% CAGR. Axiom Foods’ Oryzatein® and Roquette’s NUTRALYS® Rice Protein serve sports nutrition and meal-replacement demand, while Tsuno’s ferulic acid and glucosylceramide target cosmetic formulations. Infant food remains specification-driven: rice flour and starch offer familiar functionality, and EU rules governing infant and young-child food composition reinforce the need for validated ingredients. Pharmaceutical use remains smaller but stable because excipient and active-ingredient specifications limit substitution.

Rice Derivative Market Regional Analysis

North America

North America generated USD 6.57 billion in 2025, led by the United States at USD 5.58 billion and Canada at USD 0.99 billion. Gluten-free food, sports nutrition, and organic retail demand support purchases of rice flour, starch, and protein. FDA gluten-free labeling requirements support dedicated supply chains for allergen-sensitive products. Axiom Foods, Riceland Foods, PGP International, and Ingredion provide a regional production and formulation base. The regional constraint is premium-category concentration: growth depends on continued consumer willingness to pay for specialty foods and nutrition products.

Europe

Europe reached USD 3.70 billion in 2025 and will grow at the fastest regional CAGR of 6.8%. Germany accounted for USD 0.81 billion, the United Kingdom for USD 0.70 billion, while France, Spain, and Italy provide additional food, nutraceutical, and cosmetic demand. Farm-to-Fork policy, allergen transparency rules, and organic procurement create a regulatory advantage for certified, clean-label ingredients. BENEO operates from Germany, Ebro Ingredients connects European operations with global production, and Roquette supplies rice protein from France. Certified feedstock availability remains a constraint on organic growth.

Asia Pacific

Asia Pacific led at USD 7.51 billion in 2025 and will grow at 5.8% CAGR. China reached USD 2.85 billion, India USD 1.65 billion, Japan USD 1.20 billion, and South Korea USD 0.68 billion; Australia contributes demand for organic and gluten-free products. The region combines paddy availability with deep food-processing consumption. FAO data identifies Asia as the center of global rice production. ^{[6]Food and Agriculture Organization of the United Nations, “Rice and Rice-Derived Ingredient Information”, fao.org} Wilmar, Panjin Hetian Food, A.P. Refinery, Adani Wilmar, Gemini Edibles, and Tsuno represent distinct regional models from scale processing to specialist bioactives. Policy-led feedstock diversion remains the material regional risk.

Latin America

Latin America generated USD 1.29 billion in 2025 and will expand at 5.6% CAGR. Brazil led at USD 0.62 billion, Mexico followed at USD 0.36 billion, and Argentina adds emerging gluten-free demand. Growth follows food-processing development and demand for functional ingredients, but purchasing power and currency variability limit rapid premiumization. The region offers incremental volume potential rather than the high-value mix seen in Europe.

Middle East & Africa

The Middle East and Africa reached USD 1.13 billion in 2025 and will grow at 5.0% CAGR. Saudi Arabia generated USD 0.32 billion, the UAE USD 0.23 billion, and South Africa USD 0.20 billion. Indian rice bran oil exporters support regional supply, while the UAE operates as a re-export and food-manufacturing hub. Import dependence and lower purchasing power across much of sub-Saharan Africa constrain specification-led growth.

Rice Derivative Market Share & Competitive Landscape

Wilmar International Ltd. led the market with 12.5% share in 2025, followed by Ingredion at 8.5%, Riceland Foods at 6.5%, BENEO at 5.5%, and A.P. Refinery at 5.0%. The top five collectively held 38% of demand-side revenue, indicating moderate concentration. Wilmar differentiates through vertically integrated agribusiness scale across rice bran oil, flour, and fats. Ingredion differentiates through functional starch and flour systems, while Riceland combines cooperative feedstock access with industrial ingredient supply. BENEO competes through specialty rice formats, and A.P. Refinery focuses on extraction-scale rice bran oil production.

Major players operating in the rice derivative market include: Axiom Foods; Riceland Foods Inc.; Wilmar International Ltd.; BENEO GmbH; A.P. Refinery Pvt. Ltd.; PGP International; Panjin Hetian Food Co. Ltd.; Shafi Gluco Chem; Ingredion Incorporated; Ebro Ingredients; Adani Wilmar Ltd.; Gemini Edibles & Fats India Ltd.; Tsuno Food Industrial Co. Ltd.; and Roquette Frères.

Integrated scale players include Wilmar, Riceland, A.P. Refinery, Adani Wilmar, and Gemini Edibles & Fats, which compete through sourcing, extraction, refining, packaging, and distribution. Specialty ingredient platforms include BENEO, Ingredion, Ebro Ingredients, and PGP International, each using named starch or flour systems to serve texture, clean-label, infant-food, and bakery requirements. Protein specialists include Axiom Foods, Panjin Hetian Food, and Roquette; Axiom’s January 2025 Oryzatein® 2.0 launch is the clearest recent product-development signal in the group. Tsuno anchors the bioactive niche through gamma-oryzanol, ferulic acid, glucosylceramide, and expeller-pressed oil. Shafi Gluco Chem differentiates through rice starch, flour, and Infant Safe® rice syrup. ^{[7]Shafi Gluco Chem, “Rice Ingredients and Infant Safe”, glucochem.com}

Competitive strategy centers on vertical integration, clean-label functionality, and premium application access. Ebro Ingredients’ OryzaMYL®, OryzaFINE®, and OryzaRICH® families span starch, flour, and stabilized bran. ^{[8]Ebro Ingredients, “Rice Ingredient Portfolio”, ebroingredients.com} Ingredion’s NOVATION® Lumina, PURITY™ Alpha, and HOMECRAFT® Create families support differentiated starch and flour positioning. ^{[9]Ingredion Incorporated, “Rice Starches and Flours”, ingredion.com} BENEO’s REMY® range covers rice flour, starch, and protein. ^{[10]BENEO GmbH, “Rice Ingredients Portfolio”, beneo.com} The market is fragmented outside the leading group, leaving room for regional processors but limiting their pricing power in standardized formats.

Company Profiles

• Axiom Foods: A rice-protein specialist whose Oryzatein® and WRISE® formats target sports nutrition, meal replacements, and plant-based beverages. Its January 2025 Oryzatein® 2.0 launch centers differentiation on enzymatic processing.

• Riceland Foods Inc.: A farmer-owned Arkansas cooperative supplying ingredient rice and rice bran oil. Its cooperative structure provides feedstock integration for North American food and foodservice customers.

• Wilmar International Ltd.: The market leader operates rice bran oil, flour, and rice-derived fats activities across Asia Pacific, Africa, and the Middle East. Scale and distribution underpin its 12.5% share. ^{[11]Wilmar International, “Annual Report”, wilmar-international.com}

• BENEO GmbH: The German specialist supplies the REMY® portfolio, including Remyflo®, Remygel®, Remypure®, and Remypro®, for clean-label food and nutrition applications.

• A.P. Refinery Pvt. Ltd.: An Indian rice bran oil producer with 400 metric tons per day of extraction capacity, serving domestic and export supply chains.

• PGP International: The United States-based ABF Ingredients subsidiary focuses on PAC® pre-gelatinized rice flour for infant food, bakery, and processed food applications.

• Panjin Hetian Food Co. Ltd.: The China-based producer sells rice protein powder, peptides, and rice starch, extending competitive supply in protein and starch categories.

• Shafi Gluco Chem: The Pakistan-based supplier combines rice starch and flour with Infant Safe® rice syrup, addressing clean-label sweetener and infant-nutrition demand.

• Ingredion Incorporated: Its NOVATION® Lumina, PURITY™ Alpha, and HOMECRAFT® Create lines position rice starch and flour as functional, clean-label systems.

• Ebro Ingredients: OryzaMYL®, OryzaFINE®, and OryzaRICH® give the Spain/Belgium-based specialist coverage across starches, micronized flours, and stabilized bran.

• Adani Wilmar Ltd.: The India-listed company markets Fortune® Rice Bran Oil through consumer and industrial channels, supported by links to Wilmar and contract processing relationships.

• Gemini Edibles & Fats India Ltd.: Freedom® Refined Rice Bran Oil anchors a consumer and business-to-business model supported by three Indian manufacturing plants.

• Tsuno Food Industrial Co. Ltd.: The Japanese specialist converts rice bran into oil, gamma-oryzanol, ferulic acid, glucosylceramide, fatty acids, and feed inputs, giving it a distinct bioactive position. ^{[12]Tsuno Food Industrial, “Rice Bran Ingredients”, tsuno.co.jp}

• Roquette Frères: NUTRALYS® Rice Protein Isolate and Concentrate extend the company’s broader plant-protein portfolio into rice-based nutritional, beverage, and food applications. ^{[13]Roquette Frères, “NUTRALYS Rice Protein”, roquette.com}

Recent Industry Developments

• Jan 2025: Axiom Foods launched Oryzatein® 2.0, an enzymatically processed rice protein isolate. The launch strengthens rice protein’s position in premium sports and clinical nutrition applications.

• 2025: BENEO presented Remyflo®, Remygel®, Remypure®, and Remypro® at Fi Europe 2025. The activity confirms continued commercial investment in European rice ingredient customers.

• 2025: Shafi Gluco Chem exhibited rice starch, rice flour, and Infant Safe® rice syrup at Fi Europe 2025. The event supports its export-oriented presence in processed food and infant nutrition.

• 2025: Ebro Ingredients participated in IFE Manufacturing 2025 in the United Kingdom with OryzaMYL®, OryzaFINE®, and OryzaRICH® product families. The development reinforces its European food-manufacturing reach.